James Kirkpatrick

Institution: Institute of Pathology, University Medical Center, Johannes Gutenberg University, Mainz, Germany

C. James Kirkpatrick has a triple doctorate in science and medicine (MD, PhD, DSc) from the Queen’s University of Belfast (N. Ireland) and since 1993 is Professor of Pathology and Chairman of the Institute of Pathology at the University Medical Center of the Johannes Gutenberg University (JGU) in Mainz, Germany. Previous academic appointments were in pathology at the University of Ulm, Manchester and the RWTH Aachen.
His principal research interests are in biomaterials, including nanoparticles, in tissue engineering and regenerative medicine, with special focus on the development of human cell culture techniques, especially in co-culture systems in three-dimensions.
He is author/coauthor of 448 publications in peer-reviewed journals, has made more than 1270 presentations to scientific meetings worldwide and has an H-index of 49 (Web of Science). In his career he has supervised 100 (completed) doctorate theses (MD/PhD/DDS) at two universities (Aachen, Mainz). He is a former President of both the German Society for Biomaterials (2001-2005) and the European Society for Biomaterials (2002-2007; George Winter Award 2008). In 2010 he was awarded the Chapman Medal from the Institute of Materials, Minerals & Mining, London, UK. In addition, he is an Honorary Professor at the Peking Union Medical College in Beijing and the Sichuan University in Chengdu, China (since 2004) and a Visiting Professor at the South China University of Technology in Guangzhou (since 2011), the Nanyang Technological University (NTU) in Singapore (since 2012) and the Salgrenska Academy of the University of Gothenburg, Sweden (since 2013).

He is a former Associate Editor of the Journal of Pathology (2001-2006) and a current Associate Editor of Biomaterials (since 2002) as well as a member of the Editorial Advisory Board of several journals in the biomaterials and regenerative medicine fields. He is a member of the Scientific Advisory Board of a number of research institutes, centres of excellence and companies in biomaterials and regenerative medicine in Europe, as well as the Medical Technology Committee, Federal Ministry of Education & Research in Germany and the German Federal Institute for Drugs & Medical Devices.

He is a Fellow of the Royal College of Pathologists (FRCPath), London (since 1997), a Fellow of Biomaterials Science & Engineering (FBSE) of the IUS-BSE (International Union of Societies for Biomaterials Science & Engineering)(since 1996), a Fellow of EAMBES (European Alliance of Medical & Biological Engineering & Science)(since 2012), and a Fellow of Tissue Engineering & Regenerative Medicine (FTERM) of the Tissue Engineering & Regenerative Medicine International Society (TERMIS)(since 2012).

James Kirkpatrick 's home page